The US Food and Drug Administration approved the first cannabis-derived drug this week, but it can’t be sold until the Drug Enforcement Administration changes how it classifies the specific compound used. So what’s next?
Epidiolex treats serious forms of childhood epilepsy and contains the compound cannabidiol (CBD). Though CBD comes from cannabis, it won’t cause anyone to get high; it’s the compound THC that is psychoactive. But because it comes from cannabis and cannabis overall is classified as a Schedule I drug with “no currently accepted medical use and a high potential for abuse,” pharmaceutical companies aren’t allowed to sell it unless the DEA reclassifies CBD.
It is likely that the DEA will reclassify CBD in the next 90 days,...
Technology ===> Tech News Alert ===> PC & Mac Reviews ===> Mobile Phone News & Reviews ===> Mobile News ===> Internet News ===> Gaming News ===> Gadgets News ===> Cameras And Camcorders Review
